Bayer is Not Shying Away from Monsanto’s Controversies with Post-Merger Exec Team
Bayer, through Condon, has indicated that it is aware the merger presents an opportunity to reset public opinion about controversial technologies like GMOs and Dicamba, but the executive announcement last week suggests a complete overhaul is not in the cards.